Ireland to Purchase COVID-19 Antiviral and Monoclonal Antibody Treatments from Pfizer, GSK, and Merck

Strategic Insights -

The Irish government has confirmed that it is pursuing the purchase of COVID-19 antiviral and monoclonal antibody treatments, following discussions at a cabinet meeting. The treatments in question are manufactured by Pfizer, GlaxoSmithKline (GSK), and Merck (MSD). Ireland has already indicated its intention to participate in a European Union (EU) Joint Procurement Agreement (JPA) for the purchase of MSD's Lagevrio (Molnupiravir) and Pfizer's Paxlovid (PF-07321332; Ritonavir). Additionally, the country is a participant in an EU JPA for the purchase of the GSK monoclonal antibody product Xevudy (Sotrovimab). The Health Service Executive (HSE) is also exploring opportunities to procure antivirals through bilateral agreements at a national level.

Key Takeaways:

  • The Irish government has confirmed its intention to purchase COVID-19 antiviral and monoclonal antibody treatments from Pfizer, GSK, and Merck.
  • Ireland will participate in an EU Joint Procurement Agreement (JPA) for MSD's Lagevrio (Molnupiravir) and Pfizer's Paxlovid (PF-07321332; Ritonavir).
  • The country is already a participant in an EU JPA for the purchase of the GSK monoclonal antibody product Xevudy (Sotrovimab).
  • The HSE is exploring opportunities to procure antivirals through bilateral agreements at a national level, in advance of the completion of the relevant EU JPA.
  • A National Therapeutics Advisory Group has been established to evaluate, advise, and provide recommendations on all therapeutics with potential for use in the treatment of COVID-19 in Ireland.
  • A Therapeutics Operational Group has been established to develop the arrangements for provision of these treatments to patients who may benefit from their use.
  • Minister Stephen Donnelly has emphasized the importance of using all available tools to protect essential services and the health of those most vulnerable to COVID-19 infection.

Statistics:

  • No specific statistics are mentioned in the article regarding the number of people infected with COVID-19 in Ireland or the number of hospitalizations.
  • The article states that COVID-19 incidence is at "unprecedented levels" in Irish communities, without providing a specific number or percentage.
  • 88% of the population in Ireland has received a booster dose, according to a previous report.

Sources:

  • Minister for Health Stephen Donnelly
  • Irish government
  • EU Commission
  • Health Service Executive (HSE)
  • Al Bawaba (Albawaba.com)
  • SyndiGate Media Inc. (Syndigate.info)